Xcout Intel
Grey Wolf Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Grey Wolf Therapeutics among biotechnology companies — ranked by similarity to what Grey Wolf Therapeutics actually does, not by market-cap band.
Subscribe to see Grey Wolf Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Grey Wolf Therapeutics
Grey Wolf Therapeutics is a biotechnology company headquartered in the UK focused on delivering a new class of treatments to improve the lives of people with cancers and autoimmune disorders.
Grey Wolf Therapeutics at a glance
Grey Wolf Therapeutics is a biotechnology company headquartered in United Kingdom. Its most recent funding round, Series B, raised $50M in May 2024. Xcout tracks 16 named people at Grey Wolf Therapeutics, including Paul Stainer (Chief Operating Officer).
Grey Wolf Therapeutics leadership
- Paul StainerChief Operating Officer
- Andy PageChief Business Officer
- Tom LillieChief Medical Officer
- Peter JoyceChief Executive Officer & Co-founder
- Tom McCarthyNon-Executive Director & Co-founder
- James DodsonHead of People
10 more named people on record for Grey Wolf Therapeutics, with roles, board committees and tenure — see the full roster →
Grey Wolf Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $50M | 8 named | |
| Series B | $49M | — | |
| — | $3.3M | — | |
| — | $14M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Grey Wolf Therapeutics competitors
Ranked by semantic similarity — how close each company is to Grey Wolf Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.
Biotech
Oxford BioTherapeutics is a clinical-stage oncology company focused on developing first-in-class cancer therapeutics with a proprietary pipeline. The company operates from locations in Oxford, United Kingdom, as well as San Jose, California, and Morristown, New Jersey, in the United States.
Biotech
Nimbus Therapeutics is a biotechnology company that uses structure-based drug discovery and computational chemistry to develop small-molecule medicines. It focuses on therapeutic areas including oncology, autoimmune disease, and metabolic disorders, serving patients through internally developed programs and pharmaceutical partnerships.
Similar biotechnology company
ImCheck Therapeutics designs and develops next-generation immunotherapeutic antibodies focused on modulating the immune system through the butyrophilin and butyrophilin-like superfamily of checkpoint molecules. The company's pipeline targets treatments for cancer, infectious disease, and autoimmune disease.
Similar biotechnology company
AbolerIS Pharma is a pre-clinical stage biotech company founded in Nantes, France, specializing in the development of innovative immunomodulators and advanced biopharmaceuticals for autoimmune conditions.
Similar biotechnology company
Canopy Immuno-Therapeutics is a pre-clinical stage biotechnology company based in Haifa, Israel, focused on developing non-immunosuppressive biologics, including Antigen-Drug Conjugates, for antibody-mediated autoimmune conditions.
Similar biotechnology company
Autobahn Therapeutics, Inc. is a privately held biopharmaceutical company with its corporate office and headquarters located in San Diego, California, focused on restoring hope for patients.
Biotech
Ditto Biosciences is a company headquartered in San Francisco, US, that focuses on drug discovery. The company is involved in identifying proteins that could lead to new drugs for patients with autoimmune diseases.
Biotech
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies. These therapies are designed for the treatment of cancer and autoimmune diseases, with a facility located in Sacramento.
Similar biotechnology company
ImmunOs Therapeutics AG is a biotechnology company that develops treatments for cancer and inflammatory diseases by harnessing the human immune system. The company focuses on immuno-oncology and autoimmune therapies through a dedicated drug pipeline.
Similar biotechnology company
TRIMTECH Therapeutics is a biotechnology company headquartered in Cambridge, United Kingdom, focused on developing targeted protein degradation therapies like TRIMTAC and TRIMGLUE.
Similar biotechnology company
Pathios Therapeutics Limited is a biotech company established in 2017 and registered in England and Wales, focusing on the discovery and development of first-in-class therapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Grey Wolf Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Grey Wolf Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →